MBX
NASDAQ · Pharmaceuticals
Mbx Biosciences Inc
$65.93
-0.53 (-0.80%)
Open$67.00
Previous Close$66.46
Day High$69.40
Day Low$64.50
52W High$72.64
52W Low$9.63
Volume—
Avg Volume521.3K
Market Cap3.19B
P/E Ratio—
EPS$-2.21
SectorPharmaceuticals
Analyst Ratings
Strong Buy
16 analysts
Price Target
-28.5% upside
Current
$65.93
$65.93
Target
$47.13
$47.13
$32.34
$47.13 avg
$55.83
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 515.19M | 454.58M | 572.08M |
| Net Income | 92.27M | 88.31M | 111.14M |
| Profit Margin | 17.9% | 19.4% | 19.4% |
| EBITDA | 143.26M | 124.50M | 146.54M |
| Free Cash Flow | 88.64M | 54.29M | 70.53M |
| Rev Growth | +6.8% | +2.6% | +10.2% |
| Debt/Equity | 1.22 | 1.24 | 1.00 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |